OAL vs TATVA: Stock Comparison

Oriental Aromatics Limited vs Tatva Chintan Pharma Chem Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Tatva Chintan Pharma Chem Limited is the larger company by market capitalisation. Oriental Aromatics Limited shows a higher dividend yield and lower leverage, while Tatva Chintan Pharma Chem Limited shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Oriental Aromatics Limited and Tatva Chintan Pharma Chem Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, OAL is more favourable on 3 of 13 scored metrics and TATVA on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
TATVA is the larger company
₹4,033 Cr vs ₹1,237 Cr
P/E Ratio
TATVA has a lower P/E
78.3x vs 376.63x
P/B Ratio
OAL has a lower P/B
1.87x vs 5.15x
EPS
TATVA has higher earnings per share
₹18.84 vs ₹0.98
Dividend Yield
OAL has a higher dividend yield
0.14% vs 0.08%
Revenue Growth (TTM YoY)
TATVA has faster revenue growth
24.4% vs 11.5%
EPS Growth (TTM YoY)
TATVA has faster EPS growth
907.5% vs 180.9%
Qtr Sales Growth
TATVA has stronger quarterly sales growth
24.4% vs 11.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricOALTATVA
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricOALTATVA
Live Price₹373₹1,722.4
Day Change5.89%1.27%
Volume45,3251.56 L
52-Week High₹412.9₹1,785
52-Week Low₹228₹976.4
Distance from 52W High-9.66%-3.51%

Valuation

MetricOALTATVA
Market Cap₹1,237 Cr₹4,033 Cr
P/E Ratio376.63x78.3x
P/B Ratio1.87x5.15x
EPS₹0.98₹18.84
Book Value₹196.73₹334.03
Dividend Yield0.14%0.08%

Growth

MetricOALTATVA
Revenue Growth (TTM YoY)11.5%24.4%
EPS Growth (TTM YoY)180.9%907.5%
Qtr Sales Growth11.5%24.4%
Qtr Profit Growth181%902%

Profitability & Leverage

MetricOALTATVA
ROE0.5%5.53%
ROCE4.47%7.14%
Net Margin0.32%8.31%
Operating Margin6.6%11.13%
Debt to Equity0.61x15.4x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricOALTATVA
Promoter Holding74.17%72.02%
FII Holding0.02% 0.02 pp3.93% 0.11 pp
DII Holding0%3.11% 0.12 pp
Public Holding25.81% 0.02 pp20.94% 0.23 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Oriental Aromatics Limited and Tatva Chintan Pharma Chem Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.